Cargando…

Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study

BACKGROUND: Visceral adiposity index (VAI) has recently been suggested to be used as a surrogate of visceral adiposity. We examined if VAI could improve predictive performances for CVD of the Framingham's general CVD algorithm (a multivariate model incorporating established CVD risk factors). W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammadreza, Bozorgmanesh, Farzad, Hadaegh, Davoud, Khalili, Prof, Azizi Fereidoun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376032/ https://www.ncbi.nlm.nih.gov/pubmed/22394430 http://dx.doi.org/10.1186/1475-2840-11-20

Ejemplares similares

Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2011)

Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010)

Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010)

Beta-Cell Age Calculator, a Translational Yardstick to Communicate Diabetes Risk with Patients: Tehran Lipid and Glucose Study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2012)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2012)

Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2020)

"Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome?"
por: Hadaegh, Farzad, et al.
Publicado: (2011)

High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2008)

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
por: Barzegar, Niloofar, et al.
Publicado: (2020)

Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study
por: Kheirandish, Masoumeh, et al.
Publicado: (2014)

Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2021)

Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study
por: Sardarinia, Mahsa, et al.
Publicado: (2016)

Prehypertension Tsunami: A Decade Follow-Up of an Iranian Adult Population
por: Hadaegh, Farzad, et al.
Publicado: (2015)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022)

No Obesity Paradox—BMI Incapable of Adequately Capturing the Relation of Obesity with All-Cause Mortality: An Inception Diabetes Cohort Study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2014)

Stata Modules for Calculating Novel Predictive Performance Indices for Logistic Models
por: Barkhordari, Mahnaz, et al.
Publicado: (2016)

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016)

Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
por: Asgari, Samaneh, et al.
Publicado: (2019)

Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study
por: Masudi, Sima, et al.
Publicado: (2015)

Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
por: Toreyhi, Hossein, et al.
Publicado: (2021)

Anthropometric indices and the risk of incident sudden cardiac death among adults with and without diabetes: over 15 years of follow-up in The Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2019)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
por: Rasooli, Rahele, et al.
Publicado: (2022)

New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
por: Hadaegh, Farzad, et al.
Publicado: (2010)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2021)

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Survival Regression Modeling Strategies in CVD Prediction
por: Barkhordari, Mahnaz, et al.
Publicado: (2016)

Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study
por: Kabootari, Maryam, et al.
Publicado: (2019)

Sex differences in the association between diabetes and hypertension and the risk of stroke: cohort of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2022)

Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women
por: Hadaegh, Farzad, et al.
Publicado: (2009)

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
por: Rabani, SeyedHossein, et al.
Publicado: (2018)

Sex Specific Incidence Rates of Type 2 Diabetes and Its Risk Factors over 9 Years of Follow-Up: Tehran Lipid and Glucose Study
por: Derakhshan, Arash, et al.
Publicado: (2014)

Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Parizadeh, Donna, et al.
Publicado: (2018)

Anthropometric Indices as Predictors of Coronary Heart Disease Risk: Joint Modeling of Longitudinal Measurements and Time to Event
por: GILANI, Neda, et al.
Publicado: (2017)

Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
por: Abdi, Hengameh, et al.
Publicado: (2018)

Sex Differences in Cumulative Exposure to Metabolic Risk Factors Before Hypertension Onset: The Cohort of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ct9ihee2vpkcu6b4uj7q577id2